Chromosomal microarray analysis is superior in identifying cryptic aberrations in patients with acute lymphoblastic leukemia at diagnosis/relapse as a single assay.

CONCLUSION: Incorporation of CMA as a routine clinical test at the time of diagnosis/relapse, in conjunction with CC and/or FISH, is highly recommended. PMID: 31112375 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31112375?dopt=Abstract

Source: International Journal of Laboratory Hematology - May 20, 2019 Category: Hematology Authors: Chen C, Heng EYH, Lim AST, Lau LC, Lim TH, Wong GC, Tien SL Tags: Int J Lab Hematol Source Type: research